The Toxicity of Tau in Alzheimer Disease: Turnover, Targets and Potential Therapeutics

Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/j.1582-4934.2011.01273.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies

2013English

The Interactions of P53 With Tau and Aß Represent Potential Therapeutic Targets for Alzheimer’s Disease

Progress in Neurobiology
Neuroscience
2018English

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides With Potential for Therapy of Alzheimer Disease

PLoS ONE
Multidisciplinary
2016English

Amyloid Β and Alzheimer Disease Therapeutics: The Devil May Be in the Details

Journal of Clinical Investigation
Medicine
2003English

Measurement of Distinct Immunochemical Presentations of Tau Protein in Alzheimer Disease.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Defining Molecular Targets to Prevent Alzheimer Disease

Archives of Neurology
2005English

Seeding Selectivity and Ultrasensitive Detection of Tau Aggregate Conformers of Alzheimer Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy